Dr. Fisch is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Fruit St, Warren Building 219
Boston, MA 02114
Summary
- I am board certified by the American Board of Pathology in anatomic pathology and molecular genetic pathology. I completed my anatomic pathology residency and head and neck/endocrine subspecialty training at Massachusetts General Hospital, and my molecular pathology training in the Harvard-wide molecular genetic pathology fellowship at Brigham and Women's Hospital. My main research interest is within molecular diagnostics for tumors of the head and neck.
Education & Training
Massachusetts General HospitalFellowship, Head and Neck Pathology, 2021 - 2022- Massachusetts General HospitalResidency, Pathology-Anatomic and Clinical, 2017 - 2021
Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Molecular Genetic Pathology, 2019 - 2020
University of Maryland School of MedicineClass of 2017
Certifications & Licensure
MA State Medical License 2021 - 2026- American Board of Pathology Pathology - Anatomic
- American Board of Pathology Pathology - Molecular Genetic
Publications & Presentations
PubMed
- 5 citationsUndifferentiated Embryonal Sarcoma of the Liver With Rhabdoid Morphology Mimicking Carcinoma: Expanding the Morphologic Spectrum or a Distinct Variant?:David J. Papke, Adam S. Fisch, Sarangarajan Ranganathan, Allison F. O'Neill, Micheál Breen
Pediatric and Developmental Pathology. 2021-06-14 - 25 citationsPan-sarcoma genomic analysis of KMT2A rearrangements reveals distinct subtypes defined by YAP1-KMT2A-YAP1 and VIM-KMT2A fusions.Lucas R. Massoth, Yin P Hung, Valentina Nardi, G. Petur Nielsen, Robert P. Hasserjian
Modern Pathology. 2020-05-27 - 101 citationsClinical sensitivity and interpretation of PCR and serological COVID-19 diagnostics for patients presenting to the hospital.Tyler E. Miller, Wilfredo F. Garcia Beltran, Adam Z. Bard, Tasos Gogakos, Melis N. Anahtar
FASEB Journal. 2020-08-28
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
